Attenton, healthcare benefit consultants: Take part in our survey and share some of the trends you are seeing among your clients. A full report of the findings will be available later this year.
A much diminished 23andMe exists today, a far cry from the phenomenon that it was in the world consumer DNA testing. Could things have unfolded differently under a different leader with a different vision?
Ilant Health extended its seed round from $3 million to $5.5 million. The company garnered interest from LifeX Ventures, Celtic House Asia Partners and Cornucopian Capital.